, Tracking Stock Market Picks
Enter Symbol:

down 43.22 %

ARCA BIOPHARMA INC. (ABIO) rated Buy with price target $3.75 by Dawson James

Posted on: Wednesday,  Oct 9, 2013  9:25 AM ET by Dawson James

Dawson James rated Buy ARCA BIOPHARMA INC. (NASDAQ: ABIO) on 10/09/2013, when the stock price was $1.55. Since
then, ARCA BIOPHARMA INC. has lost 43.23% as of 10/23/2015's recent price of $0.88.
If you would have followed this Dawson James's recommendation on ABIO, you would have lost 43.22% of your investment in 744 days.

ARCA biopharma, Inc. (ARCA), formerly Nuvelo, Inc. is a biopharmaceutical company focused on developing genetically-targeted therapies for heart failure and other cardiovascular diseases. ARCA?s lead product candidate Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator is under review by the United States Food and Drug Administration (FDA), for chronic heart failure (HF). Gencaro is an oral tablet formulation, dosed twice daily. On January 27, 2009, Nuvelo, Inc. (Nuvelo) completed the merger with ARCA biopharma, Inc. (ABI). Pursuant to the Merger, Dawn Acquisition Sub, Inc. merged with and into ABI, with ABI continuing after the merger as the surviving company and a wholly owned subsidiary of Nuvelo. Pursuant to the Merger, ABI changed its name to ARCA biopharma Colorado, Inc. and Nuvelo changed its name to ARCA biopharma, Inc.

Dawson James Securities is a full service investment firm with deep expertise in healthcare, biotechnology and technology with a staff of over 50 investment professionals ensures our clients stay ahead of the constant changes in the healthcare capital markets. From our widely-respected institutional research, investment banking and high net worth services to our personalized attention for individual accounts, we provide quality service for our clients. We take pride in the quality and depth of our professionals and encourage you to contact us so we can begin serving your financial needs today.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/9/2013 9:25 AM Buy
1.55 3.75
as of 12/13/2013
1 Week down  -2.58 %
1 Month up  3.42 %
3 Months down  -2.58 %
1 YTD down  -2.58 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy